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Abstract
The ‘autism diagnosis crisis’ and long waiting times for assessment are as yet unresolved, leading to undue stress and limiting 
access to effective support. There is therefore a significant need for evidence to support practitioners in the development of 
efficient services, delivering acceptable waiting times and effectively meeting guideline standards. This study reports statisti-
cally significant reductions in waiting times for autism diagnostic assessment following a children’s health service improve-
ment programme. The average wait between referral and first appointment reduced from 14.2 to 10.4 weeks (t(21) = 4.3, 
p < 0.05) and between referral and diagnosis shared, reduced from 270 to 122.5 days, (t(20) = 5.5, p < 0.05). The proportion 
of girls identified increased from 5.6 to 2.7:1. Methods reported include: local improvement action planning; evidence based 
pathways; systematic clinical data gathering and a training plan. This is a highly significant finding for many health services 
wrestling with the challenges of demand and capacity for autism diagnosis and assessment.
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Introduction
Considerable stress is present for families and individuals 
with autism spectrum disorder (ASD), which is exacerbated 
through delayed or protracted diagnostic assessment (Crane 
et al. 2015). ASD is a heterogeneous condition and diagnos-
tic assessment across the lifespan is in many ways more of 
an art than a science, involving the interpretation of intricate 
information from a variety of sources (Matson et al. 2012). 
In a nationalised health service, aiming to provide equitable 
public services, free at the point of delivery, this complexity 
contributes to the challenge of delivering timely and effec-
tive provision, within the resources available.
Despite high levels of adherence to evidence based clini-
cal guidelines (McKenzie et al. 2016; National Institute 
for Health and Clinical Excellence (NICE) 2011; Scottish 
Intercollegiate Guidelines Network (SIGN) 2016) the aver-
age age of autism diagnosis for children has not reduced in 
the last 10 years, with the median age of diagnosis being 
55 months (Brett et al. 2016). The mean age of diagnosis 
is recently reported as 62.8 months (Oswald et al. 2015); 
89 months (Crane et al. 2015) and 105 months (Rutherford 
et al. submitted (b)) with outcome affected by age group 
being studied. The need to improve upon the delays in 
receiving assessment and diagnosis of ASD (Rutherford 
et al. 2016a; Wilson et al. 2013) and to understand how to 
adapt service delivery to meet the needs of this population 
is a research priority (Autistica 2015). Given the well docu-
mented challenge in translating research evidence into prac-
tice in healthcare, there is a need for clinical research part-
nerships to develop and evaluate solutions to this problem. 
Recent clinical research provides evidence based guidance 
to enable service providers to identify the focus for targeted 
intervention to address the challenge of reducing the wait for 
ASD assessment (Rutherford et al. submitted (a), 2016b) and 
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we were interested in whether a clinical children’s service 
could apply this evidence to improve efficiency and reduce 
the duration of assessment, whilst maintaining a high qual-
ity service.
Time Standards for Diagnostic Assessment
In order to target reductions in waiting times for assessment, 
health services need to know what length of wait is expected 
(Holzer et al. 2006) and whilst there has not been an inter-
national push to set time standards, the longstanding and 
not otherwise contested UK recommended time scale from 
referral to diagnosis in children in the National Autism Plan 
for Children (NAP-C) is 119 days (Le Couteur 2003).
For highly complex cases or where a second opinion 
is required from a tertiary service, the NAP-C recom-
mended duration from the start of the specialist assessment 
to conclusion is a further 6–8 weeks (42–56 days), taking 
the maximum recommended duration of assessment from 
referral to diagnosis for the most complex cases to 175 days 
(LeCouteur 2003). Previous research identified that many 
ASD diagnostic services do not have a means of recording 
waiting times and for those that do, few meet the NAP-C 
119 day standard (Palmer et al. 2010). To date, very few 
studies have reported on either the duration of the diagnostic 
assessment process, how to define “complexity” or results of 
interventions to reduce this duration in child health services.
The jury is still out on how we set the bar for who is 
so complex that they need to see a highly specialised team 
and who can be reliably diagnosed by a well-trained local 
team. However this seems to be an important factor in set-
ting expectations for families about optimal duration of the 
process. McClure et al. (2010) found that following a pro-
gramme of training, there was a high degree of consistency 
between local and specialist teams. Historical practice of 
ASD diagnostic assessment taking place via a small number 
of specialists was replaced by a new approach, made neces-
sary given the increasing recognition of ASD and demand on 
health services. Through broadening the skill set of commu-
nity teams in ASD assessment, they made significant reduc-
tions in waiting times, from 36 to 13 weeks.
More recently, the NICE (2016) quality statement on 
autism in children advises no longer than 3 months (12 
weeks) between referral and first assessment with no fur-
ther guidance on duration of assessment. In a recent national 
study from Scotland (McKenzie et al. 2015), the average 
wait from referral to first assessment was 200 days (SD 
209, range 0–1172 days) and the total wait from referral to 
diagnosis in child health services was 332 days (SD 319, 
range 0–1942 days) with 74% of child cases exceeding the 
119 day standard. Although it is acknowledged that more 
complex cases are expected to take longer, evidence sug-
gested that clinicians within health services do not explicitly 
adapt pathways and approaches for the needs of more or 
less complex cases (Rutherford et al. 2016c), for example 
by gathering relevant information before the first specialist 
appointment (McKenzie et al. 2015).
Rutherford et al. (submitted (a)) found that it was pos-
sible to significantly reduce the waits for autism diagnosis 
in adult health services (these were the waits between refer-
ral and first appointment and between first appointment and 
diagnosis) through implementing a 12 month programme of 
service change together with ASD specific approaches. The 
authors suggest that increased waiting times may be due to 
increased clinical complexity in some cases, and propose 
action plans to better manage services through: a focus on 
the adoption of evidence based practice as advised in clini-
cal guidelines; informed use of standardised instruments; 
establishing clear pathways which detail constructive use 
of time and tools at each stage from recognition through to 
diagnosis for more or less complex cases; consideration of 
training needs; using structured processes and proformas to 
gather diagnostic information and avoid duplication of effort 
and a planned change programme which takes account of 
local context.
The rise in waiting times is also likely to be linked to 
the widely accepted increase in recognition of ASD and 
increasing demand on services for diagnostic assessment 
(Centers for Disease Control and Prevention 2012), adding 
further evidence of the need for efficient practice to meet 
this demand.
Components of Service Improvement
Healthcare interventions to improve service provision are 
highly complex (Pawson et al. 2014) with a dynamic range 
of solutions applied, from strategic and organisational 
change, to role change or procedural, administrative and 
motivational change. All of which must take account of the 
local context as well as the evidence base. The following 
components of planned service improvement in ASD diag-
nostic services arise in the literature.
The Importance of Good Data
Good quality health data is accurate, consistent, fit for 
purpose, reliable and timely and such data is essential to 
accountability in health care (Requejo et al. 2015). However 
in UK ASD health services, data collection practice does not 
routinely meet these criteria. It is very hard to know what 
improvement is required in local areas because many do not 
have an ASD diagnostic assessment pathway. Even basic 
information, such as the number of referrals, or length of 
assessment is not routinely collected (Palmer et al. 2010). 
For health service teams to apply research evidence and evi-
dence based guidelines, the first step may be to establish 
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good quality and efficient processes for data collection, to 
inform service planning.
ASD Pathways
Following the publication of the NICE (2011) clinical 
guideline, clinicians can access related resources with 
regard to ASD pathways. Rutherford et al. (2016b) pro-
vide a review of core elements of care pathways as a com-
plex intervention to support more efficient and effective 
ASD diagnostic assessment. The ASD pathway developed 
in the current study (see Fig. 1) was based on evidence 
of processes and practice that make a difference to ser-
vice waiting times, including: recognition of the value of 
dialogue with clinicians in the development of the pathway 
and taking account of their views and experiences to sup-
port acceptance and compliance with the new pathway 
(Rutherford et al. 2016b); the value of good quality data 
to support accountability and planning (Requejo et al. 
2015); the knowledge that adherence to clinical guide-
lines is unlikely to increase waiting times (McKenzie et al. 
2016); the importance of a clear plan and process, with 
timely collection of information and a plan based within a 
theoretical framework to implement service improvement 
(Rutherford et al. submitted (a); Melton et al. 2012). For 
the intervention reported here, the pathway (Fig. 1) was 
shared with clinicians, together with more detailed path-
way guidance to inform them about processes, resources 
Fig. 1  Children’s pathway for 
assessment and diagnosis of 
ASD Children’s Pathway for Assessment and Diagnosis of ASD
1. Idenficaon of concern that ASD may be present
2. Request for General Developmental Assessment
3. Request for Specialist ASD assessment via triage team
5. Diagnosc decision, feedback and reporng
6. Post diagnosc signposng and review of child and family support 
needs
Time standard
6 weeks
4a. Local/ 
Abbreviated 
assessment
4b. Complex 
assessment
4c. Request 
rejected or more 
informaon 
required
Triage outcome
12 weeks
Referral for relevant support and intervenon 
(NB this is not diagnosis dependent)
Community Paediatrician and 
Community SLT assessment
CAMHS, Choice and Partnership 
Appointment or CAMHS 
caseworker assessment
or
and
Abbrev. 
17 weeks
Complex 
30 weeks
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available and standards at each stage in the pathway. This 
is available from authors on request.
Flexible Approaches to Assessment
The pathway guidance recommends that all assessments 
should include the core components of developmental his-
tory, contextual assessment and direct observation. Aspects 
of this assessment may be completed during the general 
developmental assessment phase or during specialist assess-
ment. There are some children with ASD, where the ASD 
signs and symptoms are easily apparent during general 
developmental assessment (stage 2 of the pathway) or at the 
point of triage (stage 3 of the pathway). It is proposed that 
these cases follow an “abbreviated pathway” without onward 
referral to a specialist team. Using reports and observation 
made by the local community staff, in a range of contexts, 
the ASD diagnosis is confirmed by two or more clinicians, 
through mapping evidence from assessments to DSM 5 cri-
teria (American Psychiatric Association 2013). A member 
of the local team, who has a relationship with the family, will 
share the diagnosis and provide literature and signposting.
Other cases are complex (NICE 2011) because of within 
child factors (such as co-morbidity) or contextual factors 
(such as co-occurring neglect or family/professional disa-
greement). A perception of complexity may also arise where 
a local team feels this is a complex case for them because of 
a misfit between staff skill set and familiarity with children 
of a particular age and developmental stage or children with 
particular differential diagnoses to consider. For these rea-
sons Autism ACHIEVE Alliance (AAA) research describing 
complexity factors within a clinical population (Rutherford 
et al. submitted (b)) has suggested, that one size does not 
fit all. Standardised instruments or referral to specialist 
assessment by expert level practitioners may be needed for 
complex cases but not for all. Flexible but informed use of 
standardised instruments is recommended (Rutherford et al. 
2016c).
Referral Management and Triage
A range of children’s community health services use triage 
to screen for inappropriate referrals and to support the most 
appropriate next steps being taken (Curran et al. 2015). In 
Child and adolescent Mental Health Services (CAMHS), 
the Choice and Partnership approach (CAPA) uses a rec-
ommended procedure: children/families newly referred 
to CAMHS are invited to an initial face-to-face ‘Choice 
appointment’ which aims to reach a shared understanding 
of needs. This occurs in place of an assessment. A range of 
options can then be offered, including signposting to other 
services, self-help strategies or appropriate specialist inter-
ventions. If the child and family choose to be seen for further 
appointments within the service, then they are invited to 
book ‘Partnership appointments’ to work on mutually agreed 
targets (Robotham et al. 2010). CAPA is widely used as a 
form of triage to manage long waiting lists through manag-
ing non-attendance, efficient resource allocation and prioriti-
sation of most needy cases (Naughton et al. 2015). Children 
with ASD may not benefit from comparisons for prioritisa-
tion with children with life threatening mental health pres-
entations. In a climate which encourages early identification 
and a preventative approach to potential challenges in ASD, 
a specific ASD triage may be helpful. Through recognition 
that there is a regular demand for ASD assessment, capacity 
for this can be planned. Multi-disciplinary ASD triage with 
experienced staff from CAMHS, Community Child Health 
(CCH) and Speech and Language Therapy (SLT), allows 
allocation of cases to abbreviated or complex pathways at 
the outset. This avoids the challenge of double waiting lists 
between local generalist and centralised specialist health ser-
vices. Complex cases do not have to go through the abbrevi-
ated team first.
Service Configuration
There is very little evidence to guide optimal service con-
figuration, however there is consensus that core multi-dis-
ciplinary diagnostic teams for children are advisable and 
should include representation from Speech and Language 
Therapy (SLT), Clinical Psychology, Psychiatry and Pae-
diatricians (NICE 2011; Rogers et al. 2016; SIGN 2016). 
AAA Research identified that younger children tended to go 
to Joint CCH and SLT services whilst older children went to 
CAMHS, with only one in eight services in the AAA study 
configured with all three professional teams. It is anticipated 
that with use of a single pathway and guidance, consistent 
expectations between services can be engendered, avoid-
ing duplication of waits between different services in the 
pathway, which are operating to the wider demands of their 
own service. This duplication can occur when a child waits 
to see a local diagnostic team who then see them and decide 
they are too complex. The child then waits again to see the 
specialist team, who do very similar assessments but have 
a different skill mix or level of skill. Duplication can also 
occur when a child waits to see one service (e.g. CAMHS) 
and then it is decided that the assessment cannot be pro-
gressed until they see another service (e.g. SLT) and the 
child waits again. Early triage to consider complexity and 
skill mix required in the team can reduce such duplication 
and thus shorten waiting times.
Training and Mentoring of Staff
Effective training can impact positively on practices which 
improve quality and efficiency of ASD diagnostic services 
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(Hathorn et al. 2014; McClure et al. 2010) and having lim-
ited staff with specialised training can impact negatively 
(Duffy et al. 2002). The National Health Service (NHS) 
Education for Scotland (NES) Autism Training framework 
(2014) was devised following review of available published 
evidence, clinical guidelines and local consultation. The 
framework permits mapping of staff skills and knowledge 
for ASD diagnostic assessment at 4 levels (informed, skilled, 
enhanced and expert practice levels). The framework can be 
used by individuals, organisations or training providers to 
identify current or future training needs and levels. Detailed 
descriptions of essential knowledge at each level are outlined 
in the framework and levels of skill required by different 
staff depend on the nature, extent and likely impact of daily 
contact with individuals with ASD, rather than defining 
levels specific to profession or position in a service. The 
levels are summarised as follows using descriptions from 
the framework: Informed level describes the requirements 
for all staff working in health and social care settings, in rela-
tion to ASD. Skilled level is required for all staff with direct 
and/or frequent contact with individuals on the spectrum or 
those who have a role with high impact on those individu-
als. Enhanced level is for practitioners with more regular 
or intense contact with individuals with ASD where their 
role focuses specifically on autism, provides specific ASD 
interventions or manages the service for individuals on the 
spectrum. The Expert level describes the highly specialist 
knowledge and skills required by practitioners who, have 
a specialist role in the care, management and support of 
people with ASD. It is not expected that staff at informed or 
skilled level undertake or lead on diagnostic assessment but 
they may contribute information to the process.
In the past ASD diagnosis was largely undertaken by a 
small number of expert practitioners, however the growing 
recognition of ASD as one of the commonest developmental 
disorders, means that health staff working with children with 
developmental delay, speech, language and communication 
impairments and mental health difficulties at all levels will 
come into regular contact with individuals with ASD and 
therefore need skills at the enhanced level. Increasingly front 
line community staff have acquired skills in assessment of 
children with ASD and therefore, when such staff do have 
enhanced or even expert skills, diagnosis can take place 
locally, with less duplication. An understanding of the cur-
rent skills and training needs of staff was a core component 
of the improvement plan.
Aims
This study aims to
a. Identify the baseline number of referrals and duration 
of ASD diagnostic assessment for children (aged 0–18) 
across a health board before a single evidence based 
ASD care pathway was in place
b. Describe the pathway development process and service 
changes implemented
c. Evaluate the effects of the new pathway for ASD diagno-
sis on knowledge of service demand, duration of assess-
ment and waiting time.
Method
Governance Processes
The local (NHS) Research and Development Department 
and the NHS Quality Improvement Team granted approval 
for this study.
Participating Health Services
There are 14 health boards across Scotland and this study 
takes place in one of these, with a population of 850,000 
representing 16% of the Scottish population. In a prevalence 
study, in the same locality, 75% of children with ASD were 
identified (Harrison et al. 2006). Previous unpublished local 
data identified that between 25 and 50% of initial referrals 
to SLT clinics and 25% of CCH referrals stated concern 
over ASD, indicating high demand within each service. 
Within this health board, there are four local authority areas 
(labelled as A–D throughout the study) with area A consist-
ing of 50% of the population, Area D consisting of 25% and 
Areas B and C making up the other 25%. Across all areas, 
seven separate local teams were identified (teams 1–7). 
Each team operated independently in the management of 
referrals, although there were some shared protocols across 
teams. Traditionally CCH and SLT teams worked jointly as 
one team, CAMHS operated as a different team, with both 
groups undertaking ASD diagnostic assessment separately. 
There were 3 teams in Area A, 2 CAMHS teams and one 
CCH/SLT team; in Area B there was a single joint CCH/
CAMHS/SLT ASD team; in Area C, there were 2 teams, 
one CCH/SLT and CAMHS team; and in area D there was 
one CCH/SLT team (with no CAMHS team). Therefore 7 
separate teams offering ASD diagnostic assessment, with 
different waiting times were included in the baseline meas-
ures. A new CAMHS team was additionally included in the 
post implementation data.
Ethnicity
This locality serves a largely Caucasian population, with 
25% percent of children from black or minority eth-
nic (BME) backgrounds and 10% with English as an 
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additional language (EAL). Individual ethnicity data were 
not collected.
Procedures
The work reported comprised several steps: (a) baseline 
information gathering about current practice and national 
guidance; (b) development of an action plan (Fig. 2); (c) 
writing and achieving consensus to implement the new 
pathway (d) setting up a clinical database for recording 
and measuring involvement in the pathway for each child 
referred (e) statistical analysis of the data. Two clinicians 
were seconded for 1 day a week for a year to undertake eval-
uation and development work reported. They were super-
vised by clinician researchers from Medical Paediatrics and 
SLT and supported by a multi-disciplinary steering group.
Baseline
We used two methods to gather baseline data.
Staff Consultation
Evaluators met with local diagnosing teams to review cur-
rent practice across the health board area. Specifically, CCH 
led teams in each area and CAMHS led teams in three of 
four areas. One clinician from each team (n = 7) was inter-
viewed about main aspects of the diagnostic services such 
as personnel involved and process followed.
Case Note Analysis
At baseline, teams 1–7 did not follow a consistent data col-
lection process for children referred for ASD assessment. 
Data were collected in a systematic way in three out of seven 
teams. These teams kept written or electronic lists of chil-
dren referred for ASD assessment, together with dates of 
referral. For four of seven teams (2 from area A, 1 each 
from areas B and C), ASD referrals were not kept in a list or 
counted as separate from the general list of referrals for all 
types of assessment.
We were therefore only able to estimate the annual num-
ber of referrals at this point. Retrospective case note analysis 
was undertaken (n = 79) using a data gathering tool adapted 
from the AAA Individual Data Collection tool (McKenzie 
et al. 2015). This bespoke, non-standardised tool was devel-
oped through consensus between expert practitioners for 
the specific purpose of data collection in this study. It was 
used to identify wait times across the different teams in this 
health board area. Data collected using this tool included: 
key demographic information; dates of referrals; dates of 
key time points along the pathway and whether a diagnosis 
of ASD was given or not.
The Local Action Plan
Evidence gathered was synthesised to form the Local Action 
Plan (Fig. 2) to serve as a focus for the range of actions 
required to implement this complex health service change. 
Seven key areas for improvement were identified: (1) devis-
ing and implementing a care pathway; (2) Improving infor-
mation gathered and shared at the pre-referral stage; (3) 
Reducing the wait between referral being accepted at triage 
and first appointment; (4) reducing the assessment duration 
at different stages in the pathway; (5) providing effective 
post-diagnostic support; (6) improvements in quality and 
adherence to ASD clinical guidelines and (7) Evaluation to 
support ongoing review and reflection.
Pathway
Evidence was used to write the pathway for assessment 
and diagnosis of children with ASD (Fig. 1) together with 
evidence based guidance. Once written, agreement to fol-
low the new pathway was obtained from all stakeholders 
and the pathway was disseminated as a written document to 
all relevant teams and through a series of single profession 
and multi-disciplinary face to face events over the course of 
2015. A pathway steering group was established, meeting 
three times per year, to monitor and review the pathway. By 
2016, all 4 areas were implementing the new pathway with 
monthly triage meetings in place.
Data Collection
A database was created to support the new pathway pro-
cesses. Data was collected for each child referred for ASD 
assessment, using the data collection tool and was under-
taken as part of routine clinical care, by clinicians and 
administrative staff.
Data Analysis
Data reported in this study was analysed for cases referred in 
a 12 month period (from the second year of pathway imple-
mentation), once practice was becoming established.
Training and Mentoring
An evaluation of current skills and training needs was under-
taken through a staff survey based on the NES Autism Train-
ing framework (n = 100). A review of the framework identi-
fied that the lowest optimal level of skills and knowledge for 
clinicians undertaking assessments which contribute to ASD 
diagnosis was the Autism Skilled level. This survey results 
(available in an unpublished report) were used to develop a 
training plan to accompany the pathway.
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Area for 
Improvement Actions
D
ev
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ca
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w
ay
• Form a local multi-disciplinary pathway steering group to establish stakeholder involvement
• Development team: write pathway, protocols and guidance 
• Disseminate and implement new pathway over a specified timescale with identified key staff to 
support local teams
Im
pr
ov
e 
pr
e-
re
fe
rr
al
 
in
fo
rm
at
io
n
Develop referrer knowledge
• Information leaflets for different staff groups and parents
• Training on recognizing ASD, assessment tools, the pathway and how to raise concerns,
Improve information provided at referral
• Provide referrers with guidance/ information about what to include with a referral 
• feedback to referrers about information provided
• Use multi-agency case discussion panels to improve assessment and to direct children to the correct 
route from the start.
Triage
• Use triage to ensure there is adequate information to proceed with ASD assessment or not
R
ed
uc
e 
w
ai
t :
 
R
ef
er
ra
l t
o 
1s
t
ap
po
in
tm
en
t
Engaging families
• Provide information to families prior to 1st appointment to set expectations
• Encourage use of parent leaflets
Collecting contextual information
• Implement new protocol guidance for gathering contextual information prior to 1st appointment
• Limit school observations to cases where there is a home/school discrepancy in questionnaires
Review staffing distribution and skill mix to create more appointments within current resources.
R
ed
uc
e 
as
se
ss
m
en
t 
du
ra
tio
n
From 1st to last appointment
• Complete diagnostic assessment in 1-2 appointments, following appropriate pre-referral 
information provided.
From making to sharing diagnosis
• Provide feedback to families on same day as diagnostic assessment (where possible).
• Develop standardised report writing protocols.
E
ffe
ct
iv
e 
po
st
 
di
ag
no
st
ic
 
su
pp
or
t
• Share consistent written  information with families at the point of diagnosis 
• Provide post diagnostic meetings with families within each locality
Im
pr
ov
e 
qu
al
ity
 a
nd
 a
dh
er
en
ce
 to
 
cl
in
ic
al
 g
ui
de
lin
es
Consistency and equity
• Develop agreed process for assessment (early developmental history; contextual assessment; direct 
observation) and diagnostic formulation using DSM5 in abbreviated and complex cases
Training and development
• Review training needs for pathway implementation and develop a training plan
• Maintain ADOS peer review locally
• Foster good communication and relationships within the team.
Planning resources to meet the need
• Review service configuration and skill mix (capacity) to accommodate demand within resources 
available 
• Ensure a core group of staff have dedicated ASD time in their job plan.
• Develop and maintain links with multi-agency and multi-disciplinary partners for input into 
diagnosis and relevant interventions.
• Make efficient use of admin support to free up the diagnostic team.
E
va
lu
at
io
n
• Audit and evaluate aspects of services in relation to standards and guidelines. 
• Maintain system of collecting information about referrals, waiting times and outcomes to support 
audit and self-evaluation.
• Conduct a parent satisfaction audit.
• Participate in research and generate research practice within clinical teams.
• Collect and share statistical information with service managers 
• Have someone to lead/champion change within the service.
Fig. 2  Local action plan for the ASD diagnostic assessment service
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Baseline Results
Baseline Results of Interview with Clinician 
from Each Service
Wide variation in practice was identified. There were differ-
ences in referral criteria. For CCH, if the child had been seen 
recently at CAMHS or had an entirely behavioural presen-
tation then a referral would not be accepted, otherwise the 
only criteria was the child presents with difficulties that may 
be ASD after general developmental assessment. Service 
configuration also varied. Within CCH the diagnostic teams 
typically consisted of a paediatrician and specialist or highly 
specialised SLT. The CAMHS diagnostic team was more 
varied including a combination of psychiatrists, clinical psy-
chologists, community mental health workers, occupational 
therapists (OTs), social workers and nurses.
Information gathered for diagnosis was generally similar, 
with all teams having staff trained in use of the ADOS—
Autism Diagnostic Observation Schedule (Lord et al. 2000). 
However the tools used differed. For example one team used 
the Adolescent Autism Spectrum Quotient (Baron-Cohen 
et al. 2006) and the Australian Scale for Aspergers (Garnett 
and Attwood 1998) to gather contextual information from 
schools whereas half the teams typically used the Social 
Responsiveness Scale (SRS) (Constantino and Gruber 
2012). This is reasonable as no specific tools for gather-
ing contextual information are specified by guidelines but 
empirically some have greater construct validity and stand-
ardisation. The timing of when information was gathered 
varied, for example, CAMHS normally included a classroom 
observation early in the process. However, CCH/SLT teams 
would only do this if the information from the standard-
ised contextual assessment questionnaires was discrepant 
between parents, educators, or other agencies who know 
child’s presentation and was not in keeping with the clini-
cal observation. This variability meant the client journey 
from 1st appointment to diagnosis varied significantly across 
teams, in terms of: the information gathered prior to referral 
for ASD assessment; the number of different contacts with 
professionals; the number and type of professionals involved 
and the types of assessments completed. Each of these fac-
tors has the potential to affect duration of assessment and 
waiting times.
Baseline Waiting Times and Referral Rates
Of the 7 teams, 4 had no mechanism for recording waiting 
times. For those clinics who were able to supply this infor-
mation none were meeting the targeted timescales. For those 
with data, the average waiting time for an initial appointment 
for ASD diagnosis was reported to be just over 6 months.
The teams estimated that across the health board area, 
there were 340 referrals in the previous 12 month period in 
2013–2014.
Baseline Case Note Analysis
From all 7 teams undertaking ASD diagnostic assessment, 
79 cases were audited. The size of the sample represents 
the relative populations served by each team. The duration 
of WAIT 1 (time between referral for specialist assess-
ment and first assessment appointment) and WAIT 2 (time 
between referral for specialist assessment and diagnosis 
shared) were measured. In the sample, the average age of 
diagnosis was 82 months (6; 10 years), with a standard 
deviation of 45 and the range was 18–214 months (17; 
10 years). There were 67 boys (85%) and 12 girls (15%), 
a ratio of 5.6:1. The average duration across all teams was 
270.2 days (Table 1).
Pathway: Key Changes
The outcome of the literature review and local scoping 
exercise led to the development of the new pathway. As 
well as being consistent with evidence based clinical 
guidelines, key features and new consensus included: a 
single pathway; a single way of recording referrals; a tri-
age process; use of the abbreviated/complex pathway; con-
sensus on contextual assessment guidance; report writing 
guidance and information leaflets about the pathway for 
staff and families. Additionally alongside the pathway we 
undertook a Training and Mentoring Project to support 
implementation through assessment of training needs and 
delivery of core training.
Table 1  Baseline assessment of waiting times
Local 
authority 
area
Service Number 
of cases 
audited
Mean duration 
from referral to 
diagnosis shared 
(days)
A 1 CCH 24 255.7
A 2 CAMHS 8 282.4
A 3 CAMHS 6 314.4
B 4 CCH and CAMHS 10 139.9
C 5 CCH 10 232
C 6 CAMHS 8 305.25
D 7 CCH 13 361.6
Total 79 All Health Board 
mean duration 
270.2 days (38.6 
weeks)
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Results Following Implementation
Referral Rate
All teams added new referrals to the database, with the 
exception of team 2 and therefore the 2016 total recorded 
referral rate continues to be an underestimate. The reason 
for non-compliance is lack of allocation of administrative 
support for this purpose. Although previous evaluation high-
lighted the inaccuracy of estimation, this service estimated 
by counting the number of ADOS assessments completed in 
2016 and estimated around 100 cases were not on the data-
base. Results showed that the actual referral rate (plus 1/8 
teams providing estimated and not actual data) was 811 per 
year; more than double the original estimated referral rate. 
The actual number of referrals recorded in each area was as 
follows: Area A, n = 303; Area B, n = 86; Area C, n = 112 
and Area D, n = 201. The new system permitted recording of 
the increase from 340 referrals per year to 711 and monthly 
referral numbers recorded have remained steady for the past 
12 months.
Gender Distribution
Information about gender of referrals (see Table 2) was only 
consistently recorded in one locality (representing 43% of 
referrals). In 2016, there were 259 referrals with completed 
assessments. Gender and positive ASD diagnosis were 
recorded for 70/85 males, 34/41 females. A diagnosis of 
“Not ASD” was given to 7/41 females and 14/85 males. In 
2 cases no diagnosis was recorded and in the remaining 116 
cases gender was not recorded. The ratio of males to females 
was 2.7:1 for referred and diagnosed cases.
Age of Referral
The total mean age of referral in 2016 was 7.9 years (range 
1.4–8.0 years); the median age of referral was 7.1 years 
(85.2 months) and the majority (54%, n = 392) of referrals 
are under the age of 8 years. Table 2 presents the age groups 
of children referred, with 22.2% (n = 158) being children 0–4 
years; 32.9% (n = 234) aged 4–8 years; 24.9% (n = 177) aged 
8–12 years; 15.8% aged 12–16 years (n = 112) and only 4.2% 
(n = 30) between 16 and 20 years.
Triage Outcomes
Triage outcomes are reported in Table 3. Of those referred 
2.3% (n = 16) had already been given the diagnosis locally 
but were still added to the database and 11.3% (n = 80) were 
allocated to an abbreviated pathway. The majority of cases 
were allocated to complex assessment with 60% (n = 426) 
being allocated their next appointment with one or more 
relevant professional group (CAMHS, SLT and CCH) and a 
further 12.2% (n = 87) being allocated to an ADOS assess-
ment as the next (complex) step following triage. The num-
ber receiving ADOS assessment after their first appointment 
was not collected but it should be stated that a proportion 
have this outcome as part of their assessment. For a small 
number, more information was requested or the referral was 
not accepted and they were removed from the list.
Table 2  Age group distribution and gender of 2016 referrals
Age group distribution of referrals
Age group 
(years)
A B C D Total number Total percentage
0–4 84 14 29 31 158 22.2
4–8 114 29 29 62 234 32.9
8–12 67 20 30 60 177 24.9
12–16 33 15 19 45 112 15.8
16–20 5 8 5 12 30 4.2
Grand total 303 86 112 210 711 100
Gender of referrals
Gender A B C D Total number Assessments com-
pleted
ASD diagnosis
Female 73 5 78 41 34
Male 210 1 211 85 70
Missing data 20 86 112 204 422 133 118
Grand total 303 86 112 210 711 259 222
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Diagnostic Rate
For cases where referral was accepted and the diagnosis was 
completed within the time being studied, we counted the 
number and percentage of cases where a positive ASD diag-
nosis was given and the number where the team concluded 
that the child did not have ASD. In the whole sample 84.6% 
(n = 219) received a positive diagnosis and 14.3% (n = 37) 
went through the assessment process with the conclusion 
that they did not have ASD (Table 4).
Waiting Times
Statistically significant reductions in waiting times for 
assessment were identified (p = < 0.05), with the service 
meeting NICE and NAP-C standards following implemen-
tation of new working practices. Waits were measured in two 
ways. Table 5 outlines WAIT 1—the time between referral 
and first appointment. The average wait across this health 
service from January to July was 10.4 weeks, which com-
pares favourably with NICE (2016) recommendations that 
this is < 12 weeks. We compared WAIT 1 in 2015 and 2016, 
using two-sample t-test (assuming unequal variances). The 
average wait times were found to be significantly different 
(t(21) = 4.3, p = < 0.05).
Data were collated and analysed in January 2017 and it 
may be helpful to explain why there is some missing waiting 
time data in Tables 5 and 6. Initially, there was a graduated 
transition for each service to start implementation and data 
collection. This is the reason for missing data in 2015. By 
2016, compliance with the pathway and data collection was 
good, as shown by waiting time data in January-July 2016. 
Cases referred in August–December 2016 were still at an 
early stage in the pathway and therefore number of com-
pleted assessments and waiting time data points is small.
Secondly we were interested in WAIT 2: time from refer-
ral to diagnosis shared, which NAP-C (2003) recommends 
is < 17 weeks. We compared the wait time between referral 
and diagnosis shared for available data from 2015 to 2016, 
across this health board using two-sample t-test (assuming 
unequal variances). The reduction in average wait times was 
found to be significantly different (t(20) = 5.5, p = < 0.05).
Table 6, shows the gradual reduction in this wait time 
from 2015 and then from January to October 2016 and the 
finding that the mean wait for diagnosis using this measure 
was 17.5 weeks. As above, the missing data from November 
to December 2016 is explained by timing of data analysis 
1–2 months later, when cases referred had not progressed 
far through the pathway. Figure 3 represents the downward 
Table 3  Triage outcomes Triage outcomes: number and percentage of referrals allocated to each initial triage outcome
Outcome at end 2016 Assessment com-
pleted
Assessment not completed Grand total
No. % No. % No. %
Abbreviated 50 19.3 30 6.6 80 11.3
Diagnosis made pre-triage 3 1.2 17 2.9 16 2.3
Complex 156 60.3 266 59.7 426 60.0
ADOS 44 17.0 43 9.5 87 12.2
Accepted at triage 609 85.8
More information requested 0 0.0 13 2.9 13 1.8
Removed from list 0 0.0 3 0.7 3 0.4
Not accepted 16 2.2
Missing data (blank) 6 2.3 80 17.7 86 12.1
Grand total 259 452 711 100
Table 4  Diagnostic rate: 
number and percentage referred 
who are diagnosed with ASD
Diagnostic rate for 2016 referrals: number and percentage where an ASD diagnosis was made (of 259 
completed assessments)
Outcome A B C D Grand total
No. % No. % No. % No. % No. %
Not ASD 19 15.4 5 13.9 5 22.7 8 10.3 37 14.3
ASD diagnosed 102 82.9 30 83.3 17 77.3 70 89.7 219 84.6
Incomplete/missing data 2 1.6 1 2.8 0.0 0.0 3 1.2
Grand total 123 36 22 78 259
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trend and includes a comparison with 2015 data, showing 
this trend seems to be genuine.
Training and Mentoring Outcomes
The survey sent to all CCH, CAMHS and SLT staff found 
that there was no one group who felt they had full knowledge 
in any of the identified areas of the NES autism training 
framework (NHS Education for Scotland 2014). Staff rated 
themselves at different levels across different competencies 
and a range of training needs were identified at each level. 
A training and mentoring portfolio tool was piloted that 
outlines knowledge and skills levels required for the autism 
skilled, autism enhanced and autism expert levels.
Information leaflets for universal services including 
GPs, Health Visitors, nurseries and schools were written 
which outline the ASD pathway and referral routes. These 
give referrers guidance on how to recognise ASD, what 
information they should gather, how to refer and what to 
expect following a referral. These leaflets are intended 
to be used alongside training for professionals work-
ing at the informed and skilled levels. At skilled level, 
uni-professional knowledge and skill requirements were 
summarised with signposting to e-learning modules. At 
enhanced level, a training day for 90 delegates was organ-
ised, covering core components of ASD assessment and 
diagnosis. The recordings and slides are available on the 
intranet of this health board as a permanent resource. At 
the enhanced level, a mentoring portfolio was produced 
and is intended for use in addition to training days. Prac-
titioners are supported by a more experienced clinician 
within the diagnostic team. The portfolio consists of sug-
gested activities to observe (e.g. parent interview); written 
examples (e.g. a feedback report) and opportunities for self 
Table 5  WAIT 1: Wait from referral accepted to first appointment
Referral to first appointment average wait time in 2016 (for completed assessments) in weeks
2015 A B C D Grand total
Jan 8.2 21.1 16.5
Feb 7.8 30.5 15.8
Mar 10.5 15.7 12.2
Apr 13.2 22.6 17.2
May 13.2 15.2 13.6
Jun 14.7 23.8 17.3
Jul 14.5 21.5 17.6
Aug 15.1 13.6 14.9
Sep 14.5 9.7 13.0
Oct 11.8 10.8 11.4
Nov 9.0 16.4 11.2
Dec 8.7 25.2 10.2
Average across health board area for avail-
able data 2015
14.2 weeks
2016 A B C D Grand total
Jan 11.6 6.4 8.1 10.5
Feb 14.6 1.0 1.2 12.4
Mar 11.4 10.1 7.9 10.4
Apr 13.9 7.5 6.6 10.0
May 10.0 6.4 8.5 8.5
Jun 11.9 5.0 6.9 9.0
Jul 16.1 9.8 7.1 11.8
Aug 11.7 7.5 9.1
Sep 12.0 12.0
Oct 6.8 6.8
Nov
Dec 2.9 2.9
Average across health board area from Janu-
ary to July 2016
10.4 weeks
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and peer reflection on practice in using skills observed. 
For the smaller number of clinicians at expert level, there 
is a system of ADOS peer review. The steering group are 
exploring ways of increasing skills for other standardised 
tools including the ADI-R.
Service User Feedback
Parental feedback on the assessment process was gathered 
via telephone interview with a small number of families 
(n = 7) at time of publication. Key themes were identified 
and the general feedback about the assessment experience 
was positive. Issues around post diagnostic support were 
raised. Further service user feedback will continue to be 
sought to evaluate the impact of the pathway.
Table 6  WAIT 2: Wait from referral for specialist assessment to diagnosis shared
Referral to diagnosis shared: average wait time in 2015 and 2016 (for completed assessments) in weeks
2015 A B C D Monthly average
Jan 29.1 22.6 24.7
Feb 34.2 35.8 34.8
Mar 32.2 34.0 32.8
Apr 30.8 28.1 29.6
May 30.9 20.4 28.8
Jun 26.4 25.9 26.3
Jul 30.0 29.2 29.7
Aug 24.6 15.9 23.3
Sep 22.8 16.9 21.5
Oct 17.3 16.0 16.9
Nov 25.5 29.9 21.2 24.8
Dec 23.4 24.9 35.5 24.4
Average across health board area for avail-
able data 2015
26.4 weeks
2016 A B C D Monthly average
Jan 22.2 24.4 18.8 15.5 20.9
Feb 24.4 23.0 11.7 11.0 22.4
Mar 18.4 22.2 25.1 14.4 18.7
Apr 18.9 23.2 28.9 9.5 17.2
May 18.1 28.1 14.7 11.7 15.7
Jun 17.9 10.1 10.9 10.9 13.7
Jul 19.8 17.3 15.4 13.6 16.7
Aug 18.0 12.6 12.8 13.9
Sep 12.8 7.0 11.7
Oct 10.0 11.1 10.5
Nov
Dec
Average across health board area, January 
to October 2016
20.0 21.1 16.7 12.1 17.5 weeks
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Discussion
The aim of the present study was to examine the effect of an 
evidence based pathway for diagnostic assessment of ASD 
in reducing the wait time between referral and sharing the 
outcome of ASD diagnostic assessment in a children’s ser-
vice delivered jointly by CAMHS, CCH and SLT.
Referral Rates
The study identified that without a systematic process for 
collecting data, the demand for ASD diagnostic assess-
ment was vastly underestimated (by over 50%). In 2014 the 
estimated number of referrals was 340 and in 2016 it was 
found to be 711 with 7/8 teams providing this data consist-
ently, with a further 100 estimated from 1/8 teams. This 
finding has significant implications in relation to accurate 
service planning for capacity to meet demand using service 
improvement methodology (NHS Scotland 2017; Scottish 
Government 2010). Although ongoing challenges with full 
compliance in data collecting by clinical teams presents an 
ongoing issue, the study has provided more accurate evi-
dence of the minimum number of children being referred 
each year and the fact that this now remains steady suggests 
a good degree of accuracy. Clinicians will benefit from sup-
port of data management specialists to identify an effective 
way of gathering this information and we recommend that a 
national approach is developed in order to budget effectively 
and manage the need for ASD health services. Referral rates 
over 2016 have remained steady suggesting that we can plan 
to meet this demand with greater confidence than in the past.
Gender and Age Distribution
Where this data was collected, there were more boys referred 
than girls, which is in keeping with international consen-
sus (Rutherford et al. 2016a). However the reducing ratio 
of boys to girls of 2.7:1 (from 5.6:1 at baseline) could be 
indicative of a trend towards greater recognition of girls, 
supported by awareness raising as outlined in the local 
action plan (Fig. 2).
At baseline, the mean age of referral was lower at 
6;10  years and after implementation this had risen to 
7.9 years (93 months) which may be explained by the greater 
recording of CAMHS cases. However this is still broadly in 
keeping with other studies. The median age was 7.1 years 
(85.2 months), which is higher than reported findings from 
a range of studies over the last 10 years (Brett et al. 2016). 
It is not unexpected that 54% of referrals were under the age 
of 8 years and that number in the over 12 age groups, were 
smaller. Further work to support earlier recognition, through 
awareness raising and training of referrers is indicated.
Benefits of Pathway Implementation
The pathway has improved consistency of practice. Prior 
to implementation there was a great deal of inconsistency, 
identified in the baseline interviews with clinicians and the 
case note analysis. Differences were identified in relation 
to time taken to complete an assessment, referral practice, 
number of contacts taken to make an assessment, the nature 
of the assessment undertaken and the reporting of informa-
tion. It is likely that this would be confusing for families and 
non-health staff also working to meet the children’s needs. 
No leaflets or information were available to explain the refer-
ral and diagnostic assessment expectations. Following the 
implementation of the pathway there is now clear and avail-
able guidance for staff and information leaflets for families. 
Further evaluation of patient and staff experience and under-
standing of the pathway would be beneficial.
Diagnostic Rate
Of those accepted at triage and for whom assessment was 
completed, 86% were given a diagnosis of ASD. Our inter-
pretation of this is positive evidence of the effectiveness 
of the pathway which includes triage and referral man-
agement, a flexible approach to abbreviated and complex 
assessments, as well as very clear guidance and training 
for staff. As a result, there are proportionately fewer chil-
dren who go through the full process, who do not have 
ASD. This is important in reducing the risk of unneces-
sarily raising parental concern over ASD when it is not 
present (Hedley et al. 2016). We have found relatively few 
studies with which to compare our findings on clinical 
diagnostic rate; McClure et al. (2010) reported that only 
17/38 children assessed (45%) received an ASD diagnosis.
Waiting Times from Referral to First Appointment
In contrast to previously reported waiting times (McKen-
zie et al. 2015), the evidence reported indicates that this 
service is able to meet the NICE (2016) standard for 
3 months between referral for specialist assessment (fol-
lowing general developmental assessment (GDA) and first 
appointment). Our results provide firm evidence rather 
than expert opinion that this is a reasonable standard to 
set. We hypothesise that a range of factors have contrib-
uted to more effective use of clinical time: better refer-
ral guidance, use of the abbreviated pathway and triage, 
together with a planned approach to training and mentor-
ing within all members of diagnosing teams and not just 
a few expert practitioners. There has been some debate 
about how we define the point of referral and we have fol-
lowed the NAP-C (LeCouteur 2003) and AAA guidance 
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(McKenzie et al. 2015) which take this date as the date 
referred for specialist assessment. It does not include the 
period of time pre-referral or during general developmen-
tal assessment (GDA) often conducted by community staff, 
which is necessary to establish whether an ASD assess-
ment is indicated. Because this pathway was specifically 
focussed on aspects of the service specific to ASD, we did 
not calculate within service waiting times for GDA. Dur-
ing this year within service waits varied: for SLT (within 
12 weeks) CCH (within 12 weeks). For CAMHS Choice 
appointments occur within 6 weeks and the wait between 
Choice appointment and allocation of a caseholder to start 
GDA was over 30 weeks. The high rates of positive ASD 
diagnoses (at 86% of referrals) suggest that the processes 
in place, support good use of clinical time and children 
not being unnecessarily sent to specialist teams when their 
difficulties are not explained by ASD.
Waiting Times from Referral to Diagnosis Shared
There has been a steady downward trend in waiting times. 
During the consultation period, staff were alerted to the need 
to change practice and participated in discussions about how 
this could be done. It is possible that the increased focus 
on ASD service issues contributed to the reduction in the 
average duration of assessment from referral to diagnosis 
shared from 270 days in 2014 to 250 days in February 2015. 
After 12 months of pathway implementation the wait was 
146.3 days (20.9 weeks) in January 2016 and the 10 month 
average for January to October 2016 was 122.5 days (17.5 
weeks). In the current NHS climate in the UK, this sta-
tistically significant reduction in wait times (t(20) = 5.5, 
p = < 0.05) between 2015 and 2016 is a highly noteworthy 
finding. Through using evidence based clinical guidelines 
and literature evidence to write a pathway and adapt multi-
disciplinary working practices, a large clinical service can 
establish a system for recording and monitoring the pathway 
and also maintain a more efficient service as evidenced by a 
reduction in duration of assessment over a two year period.
Feasibility of the Pathway Implementation
Monthly triage meetings have been attended by a representa-
tive from CAMHS, CCH and SLT. While this is a demand 
on clinical time, the data reported and practitioner feedback 
suggest it is an important part of the solution for reasons 
outlined below. The meetings have: supported compliance 
with the pathway and increased the amount of joint working 
by allowing ongoing discussion and clarification between 
staff in different professional groups; provided quality assur-
ance for the abbreviated pathway by reviewing information 
from community teams to ensure that a robust assessment 
is completed; provided a forum for discussion and action in 
complex cases; ensured that referrals were only accepted 
when there was adequate information available and therefore 
appointments were offered only when clinicians were in a 
position to use their time well (e.g. avoiding clinic appoint-
ments with no contextual assessment information); acted 
as a point of contact for referrers where they could discuss 
complexity and uncertainty and support effective decision 
making; where referrals bounced between agencies, the 
triage team could make a clear decision about who would 
complete the assessment and the team provided responsive 
management of staff absence or gaps in a particular part of 
the locality—e.g. staff or clinics were moved to avoid unfair 
waits and the triage team monitored referrals to prioritise 
where needed or to ensure cases remain under discussion 
until the pathway is complete. The NAP-C plan assumes 
that there is a wait between local and specialist teams (maxi-
mum 3 months) rather than the approach taken here, where 
there is triage after the general developmental assessment, 
to allocate to either a local (also referred to as abbreviated) 
or specialist (complex) process at the outset thus preventing 
the double within service wait.
The abbreviated pathway was applied on average in 
11.3% of cases and in one locality was as high as 19%. In 
such cases, the first professionals who have completed the 
general developmental assessment prior to “referral” to tri-
age for specialist assessment also complete the ASD assess-
ment without involvement of another tier of practitioners. 
This has been supported by training and mentoring, so that 
the community paediatrician or CAMHS case worker (at the 
enhanced or expert level) completes the same early develop-
mental history and contextual assessment questionnaires. A 
direct observation of the child is also an essential compo-
nent. The SLT completes an ASD specific communication 
assessment and a member of the team gathers information 
from education colleagues, which may include a school 
observation. In the “abbreviated” pathway, full adherence 
to clinical guidelines is maintained and diagnosis is made 
through consideration of reports and observations in relation 
to DSM 5 criteria (American Psychiatric Association 2013). 
Families receive the same post-diagnostic information and 
an assessment report, detailing the process and outcome 
and any follow up referrals or assessments (e.g. genetics) 
are undertaken in the same manner. It is an aspiration to 
continue to increase the number of abbreviated assessments 
undertaken. The benefits to families of seeing fewer people 
and receiving more local care are only anecdotal at present 
and it would be helpful to review both the experiences of 
staff and families and the robustness of diagnoses made in 
this manner.
Future research to ensure that diagnoses made using the 
abbreviated pathway are robust, would be helpful. In the 
US context, concerns have been raised about children who 
have received “educational certification” of ASD diagnosis 
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through school, which is used as an “abbreviated type” 
approach. In this study we were mindful of the need to evi-
dence that health staff making the “abbreviated” diagnosis 
in a multi-disciplinary team have applied a robust process 
and reached a valid conclusion. Until we have more concrete 
research evidence, diagnostic robustness can be assumed 
if the team has: followed the local pathway guidance; fol-
lowed national clinical guidelines and have the appropriate 
knowledge training as evidenced using the NHS ASD train-
ing framework.
Limitations
One limitation of the current study was that data collection 
was undertaken by clinicians, leading to some inconsistency 
in recording before data cleaning. For example, different 
codes were used by staff to record the same thing or date 
format varied. This did not affect data accuracy.
A further limitation is the missing and incomplete data 
collected following implementation. The reasons for this 
have been explained within the results section and are fur-
ther reported below. The baseline data was complete and for 
the data following implementation, there was no missing 
data for age at referral or triage outcomes.
The first type of incomplete data following implementa-
tion was for gender of referrals. These data were not col-
lected in all localities. Gender was only recorded in one 
locality of the four, representing 43% of the dataset, with 
data from 143 cases. This sample size was considered wor-
thy of report, although it is a subset of the entire sample. In 
future we would seek to collect this data for all cases.
The second type of incomplete data was for waiting 
times or diagnostic rate and is explained by the timing of 
the study. The study took place over a specified timeframe 
and 711 referrals were recorded as they came in. For all 
cases there was data for age of referral, number of referrals 
and triage outcome. Of these cases, 259 were completed 
and 453 referred cases were still undergoing assessment at 
the close of the timeframe. The later referred (453) cases 
had not progressed through the pathway to completion of 
assessment and were therefore not included in calculation of 
waiting times or diagnostic rate. Despite this limitation, we 
have explicitly reported the nature of the data for transpar-
ency. The sample size is large and therefore still considered 
important in this under-researched area.
The lack of inclusion of CAMHS cases in one local-
ity, leading to a potential underestimate of the number of 
referrals, limits our ability to provide complete accuracy in 
referral number. Although there is strong evidence of the 
reliability of diagnoses made by experienced clinicians using 
evidence based guidelines (Charman and Baird 2002), this 
study does not provide secondary corroboration of diag-
nostic accuracy. The study does not report on individual 
ethnicity or socioeconomic status, which might be important 
variables to include in future studies.
Conclusions and Implications for Practice
This study suggests that the service improvement approach 
followed, including the development of this single local 
pathway has been successful and has led to a significant 
reduction in waiting times. We strongly commend the bene-
fits of good data collection and management to inform effec-
tive service planning. The intervention has been manageable 
and has been shown to have good feasibility within a large 
UK clinical service, receiving over 700 referrals per year 
and which shares universal challenges of recruitment and 
retention; succession planning and increasing demand for 
ASD diagnostic services without any increase in resource 
to meet the need. There is potential for short term resource 
to support the service improvement programme, resulting in 
sustainable changes in practice because this was not a small 
test of change but a highly evidence based model across a 
whole service. The gender ratio (2.7:1) suggests that more 
girls are being identified and the aspiration to support the 
recognition of girls may be having an effect. It would be 
helpful to continue to monitor this. Across all teams there is 
an aspiration that 25% of cases follow the abbreviated path-
way, together with continued awareness raising to reduce the 
age of referral to support earlier diagnosis.
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